Dendritic cell-based immunotherapy in myeloid leukaemia: translating fundamental mechanisms into clinical applications
/in Acute Leukemia, International Publications /von 2009-01-01 / Handb Exp Pharmacol 2009;(188):319-48The efficient generation of immunocompetent dendritic cells from leukemic blasts in acute myeloid leukemia: a local experience
/in Acute Leukemia, Dendritic Cells, International Publications /von 2008-09-20 / Pathol. Oncol. Res. 2009 Jun;15(2):257-67Dendritic cell vaccines in acute leukaemia
/in Acute Leukemia, International Publications /von 2008-09-01 / Best Pract Res Clin Haematol 2008 Sep;21(3):521-41Potential of dendritic-cell immunotherapy for relapse after allogeneic hematopoietic stem cell transplantation, shown by WT1 peptide- and keyhole-limpet-hemocyanin-pulsed, donor-derived dendritic-cell vaccine for acute myeloid leukemia
/in Acute Leukemia, International Publications /von 2008-04-01 / Am. J. Hematol. 2008 Apr;83(4):315-7Efficient monocyte-derived dendritic cell generation in patients with acute myeloid leukemia after chemotherapy treatment: application to active immunotherapy
/in Acute Leukemia, International Publications /von 2008-01-22 / Exp. Hematol. 2008 Mar;36(3):329-39Quantitative expression of Toll-like receptor-2, -4, and -9 in dendritic cells generated from blasts of patients with acute myeloid leukemia
/in Acute Leukemia, International Publications /von 2008-01-15 / Transfusion 2008 May;48(5):861-70Large-scale generation of autologous dendritic cells for immunotherapy in patients with acute myeloid leukemia
/in Acute Leukemia, International Publications /von 2007-09-01 / Transfusion 2007 Sep;47(9):1588-94Dendritic cell vaccines for leukemia patients
/in Acute Leukemia, Chronic Leukemia, International Publications /von 2007-03-01 / Expert Rev Anticancer Ther 2007 Mar;7(3):275-83Dendritic cell-based immunotherapy in acute and chronic myeloid leukaemia
/in Acute Leukemia, International Publications /von 2007-02-27 / Biomed. Pharmacother. 2007 Jul;61(6):306-14IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de